Cardiome Pharma Articles
Merck & Co returns vernakalant rights to Cardiome
27 September 2012
Merck & Co drops development of oral vernakalant
20 March 2012
European approval for Merck & Co/Cardiome’s IV Brinavess; added use for AstraZeneca’s Seroquel recommended
2 September 2010
Showing 1-4 of 4 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
